Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
Year: 2011
Type: article
Abstract: Amyloid imaging with [(11)C]Pittsburgh Compound-B (PiB) provides in vivo data on plaque deposition in those with, or at risk for, Alzheimer's disease (AD). We performed a gene-based association analysis of 15 quality-controlled amyloid-pathway associated candidate genes in 103 Alzheimer's Disease Neuroimaging Initiative participants. The mean normalized PiB uptake value across four brain regions known to have amyloid deposition in AD was used as a quantitative phenotype. The minor allele of an intronic SNP within DHCR24 was identified and associated with a lower average PiB uptake. Further investigation at whole-brain voxel-wise level indicated that non-carriers of the minor allele had higher PiB uptake in frontal regions compared to carriers. DHCR24 has been previously shown to confer resistance against beta-amyloid and oxidative stress-induced apoptosis, thus our findings support a neuroprotective role. Pathway-based genetic analysis of targeted molecular imaging phenotypes appears promising to help elucidate disease pathophysiology and identify potential therapeutic targets.
Source: Brain Imaging and Behavior
Authors: Shanker Swaminathan, Li Shen, Shannon L. Risacher, Karmen K. Yoder, John D. West, Sungeun Kim, Kwangsik Nho, Tatiana Foroud, Mark Inlow, Steven G. Potkin, Matthew J. Huentelman, David W. Craig, William J. Jagust, Robert A. Koeppe, Chester A. Mathis, Clifford R. Jack, Michael W. Weiner, Andrew J. Saykin, the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Institutions: Indiana University School of Medicine, Indiana University Indianapolis, Regenstrief Institute, Rose–Hulman Institute of Technology, University of California, Irvine, Translational Genomics Research Institute, Lawrence Berkeley National Laboratory, University of California, Berkeley, University of Michigan, University of Pittsburgh, Mayo Clinic, San Francisco VA Medical Center, University of California, San Francisco
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,790
Funders: National Science Foundation, Foundation for the National Institutes of Health, U.S. Department of Energy, Alzheimer's Association, Dana Foundation, Families of Spinal Muscular Atrophy, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Novartis, Roche, Muscular Dystrophy Association, CHDI Foundation, Indiana Clinical and Translational Sciences Institute, Indiana State Department of Health, Mayo Foundation for Medical Education and Research, Medpace, Synarc, Alzheimer's Disease Neuroimaging Initiative, University of Pittsburgh, Indiana University-Purdue University Indianapolis, Northern California Institute for Research and Education, Dainippon Sumitomo Pharma, Elan, Eisai, Otsuka Pharmaceutical, Mitsubishi Tanabe Pharma Corporation, National Institutes of Health, U.S. Food and Drug Administration, Genentech, University of California, Los Angeles, U.S. Public Health Service, Allergan, University of California, San Diego, Avid Radiopharmaceuticals, National Institute on Alcohol Abuse and Alcoholism, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Biomedical Imaging and Bioengineering, U.S. National Library of Medicine, National Center for Research Resources
Awards: G1133087115, Function BIRN, Dopaminergic Function in Alcoholism, UC Davis Alzheimer's Disease Core Center, Indiana Alzheimer Disease Center, Molecular and Functional Imaging of Age Related Cognitive Decline, Parkinson Disease Collaborative Study of Genetic Linkage, Genetic Analysis of Hip Fragility, III: Small: Collaborative Research: A Large-Scale Data Mining Framework for Genome-Wide Mapping of Multi-Modal Phenotypic Biomarkers and Outcome Prediction, Amyloid Imaging Agents for Position Emission Tomography, G2178074841, National Research Roster of Huntington Disease Patients and Families, G2835601961, Heart Imaging Agents: A Structural-Mechanistic Study, G29951154, G3048026193, G3146424788, G3218891203, Indiana Clinical and Translational Science Institute-T32 Program TL1, G3367276031, PET Study of Biochemistry and Metabolism of the CNS, Design and Analysis of Multi-Staged Association Studies Using Pooled Genomic DNA, Genetic Variation in KIBRA and its role in Human Episodic Memory, G3870774570, Genomic Association Study of Bipolar Disorder, G3966393351, "MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies", G4196769506, G4401988282, Transdisciplinary Imaging Genetics Center (1 of 2)(RMI), Neurochemical Endophenotype Responses to Pain-Stress, G4496800825, SPHARM Shape Modeling and Analysis Toolkit for Brain Imaging, Indiana Clinical and Translational Science Institute (UL1), Evaluating and Extending Our Hypothetical Model of Alzheimer's Biomarkers, Alzheimer's Disease Genetics Consortium, Resource for MRI of Neurodegenerative Disorders, Alzheimer's Disease Neuroimaging Initiative, G5855489481, Amyloid Imaging in Frontotemporal Dementia and Alzheimer's Disease, G6206414941, PD GWAS Consortium, Neural Mechanisms of Chemotherapy-Induced Cognitive Disorder, High Field Neuroimaging of Epilepsy, Memory Circuitry in MCI and Early Alzheimerâs Disease Prodrome: Molecular Drivers, G7619289898, Amyloid Imaging, VMCI, and Analysis for ADNI, Prediction of cognitive decline with structural, diffusion, and perfusion MRI, Dopamine, prediction error, and human alcohol consumption, G7805897153, Alzheimer's Disease Cooperative Study, G798517211, G8004032478, Assessment of the Dopamine System in Fibromyalgia, The Aging Brain: Vasculature, Ischemia, and Behavior, Neurochemistry of Opiate Abuse Risk in Chronic Pain, Indiana University/Regenstrief Institute Biomedical Informatics Research Training, Genetic Determinants of Bone Fragility, G9000038603, G9000074849, G9000122335, G9000249026, Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure, Frontotemporal Dementia: Genes, Images, and Emotions, Alzheimer's Disease Neuroimaging Initiative (ADNI4), National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), New Approaches to Dementia Heterogeneity, G920654007, G992581308
OpenAlex ID: W2147158198
